Geneoscopy
Business Services · Missouri, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2220 Welsch Industrial Ct, St. Louis, Mi...Phone Number
(314) 887-7777Website
www.geneoscopy.comRevenue
$18.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
3
1
1
1
About Geneoscopy
Geneoscopy Inc. is a life sciences company focused on the development of diagnostic tests for gastrointestinal health. Geneoscopy's lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded Breakthrough Device Designation from the U.S. FDA for its ability to reduce morbidity associated with colorectal cancer through advanced adenoma detection. Indicative of its breakthrough status, preliminary trials suggest that the diagnostic can detect these lesions at a higher rate than all existing noninvasive screening tests.Explore more
Geneoscopy Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Geneoscopy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Geneoscopy recently announced quarterly report
Check if Geneoscopy has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Geneoscopy has new funding data
Congratulate Masked Content for being promoted to Masked Content at Geneoscopy
Geneoscopy, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Geneoscopy had a recent Job posting/layoffs
Check out if Geneoscopy is spiking on competitors!
Product Launch: Get notified when Geneoscopy launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Geneoscopy as Masked Content
Find more new buyers
Compare Similar Companies to Geneoscopy
Compare insights from companies similar to Geneoscopy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Geneoscopy is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Geneoscopy is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Geneoscopy.
Geneoscopy financials insights
Gather financial insights about Geneoscopy, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$6.9M
2020
Debt
$150K
2021
Series B
$105M
2025
Series C
$105M
Geneoscopy Tech Stack
A closer look at the technologies used by Geneoscopy
See more technologies
Most Recent Scoops
Person-Based
Product Launch, Medical Research
Person-Based
Partnership, Medical Research
Person-Based
Product Launch, Medical Research
Person-Based
Partnership, Medical Research, Public Health
Person-Based
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Geneoscopy
Sign Up For FreeTo access detailed company insights
Geneoscopy Inc. is a life sciences company focused on the development of diagnostic tests for gastrointestinal health. Geneoscopy's lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded Breakthrough Device Designation from the U.S. FDA for its ability to reduce morbi... Read More
